Abstract
BackgroundIntroduction of biological disease modifying antirheumatic drugs (DMARDs) in the treatment of Psoriatic arthritis (PsA) have altered the therapeutic approach of these patients showing a good outcome.ObjectivesThe main purpose of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
